Andrea Hui Austin, Aleksandra L Lindgren, Kathleen M Welsh
{"title":"Oral Ivermectin for the Treatment of Rosacea-Associated Blepharitis: Case Report","authors":"Andrea Hui Austin, Aleksandra L Lindgren, Kathleen M Welsh","doi":"10.19080/jojo.2022.09.555759","DOIUrl":null,"url":null,"abstract":"Blepharitis is an inflammatory condition of the eyelids managed by primary care providers, ophthalmologists, and dermatologists. It can be associated with allergies, infections, seborrheic dermatitis, rosacea, eczema, and psoriasis. In both cutaneous and ocular rosacea, overgrowth of Demodex has been implicated as a causative factor. We present a case of recalcitrant rosacea-associated blepharitis treated successfully with oral ivermectin. Oral ivermectin can be an advantageous option for rosacea-associated blepharitis resistant to other treatment options due to its targeted action, once-a-day dosing and minimal adverse effects.","PeriodicalId":91023,"journal":{"name":"JOJ ophthalmology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JOJ ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.19080/jojo.2022.09.555759","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Blepharitis is an inflammatory condition of the eyelids managed by primary care providers, ophthalmologists, and dermatologists. It can be associated with allergies, infections, seborrheic dermatitis, rosacea, eczema, and psoriasis. In both cutaneous and ocular rosacea, overgrowth of Demodex has been implicated as a causative factor. We present a case of recalcitrant rosacea-associated blepharitis treated successfully with oral ivermectin. Oral ivermectin can be an advantageous option for rosacea-associated blepharitis resistant to other treatment options due to its targeted action, once-a-day dosing and minimal adverse effects.